Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Ng, Louisa ^a   Khan, Fary ^b   Mathers, Susan ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Calvary Health Care Bethlem Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INTEGRATION; MOTOR NEURON DISEASE; MULTIDISCIPLINARY CARE; PATIENT CARE; QUALITY OF LIFE; REVIEW; SURVIVAL; SYSTEMATIC REVIEW; THERAPY EFFECT;

EID: 55149098367     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007425     Document Type: Review

References (30)

1. AMNDR 2005 AMNDR Steering Committee. Australian Motor Neurone Disease Registry. World Federation of Neurology Meeting. 2005.
2. Anderson 2005 Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al.EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. European Journal of Neurology 2005 Dec;12(12):921-38.
3. Ashworth 2006 Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1102/14651858. CD004156]
4. Brooks 1994 Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. Journal of the Neurological Sciences 1994;124(Suppl):S96-S107.
5. Brooks 2000 Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology, Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and other motor neuron disorders 2000;1(5):293-9.
6. Brown 1995 Brown RH. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80(5):687- 92.
7. CNTF 1996 The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale: Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology 1996;53(2):141-7.
8. Cookson 1999 Cookson MR, Shaw PJ. Oxidative stress and motor neuron disease. Brain Pathology 1999;9(1):165-86.
9. Egger 1998 Egger M, Smith GD. Bias in location and selection of studies. British Medical Journal 1998;316(7124):61-6.
10. Forsgren 1983 Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurologica Scandinavica 1983;68(1):20-9.
11. Francis 1999 Francis K. Bach JR. DeLisa JA. Evaluation and rehabilitation of patients with adult motor neuron disease. Archives of Physical Medicine & Rehabilitation 1999 Aug;80(8):951-63.
12. Greener 2002 Greener J, Langhorne P. Systematic reviews in rehab for stroke: issues and approaches to addressing them. Clinical Rehabilitation 2002;16(1):69-74.
13. Handbook 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
14. Hardiman 2007 Hardiman O. Multidisciplinary care in motor neurone disease. In: Kiernan M editor(s). The Motor Neurone Disease Handbook. Prymont: Australasian Medical Publishing Company Limited, 2007.
15. ICF 2001 International Classification of Functioning, Disability and Health (ICF). World Health Organisation (WHO) 2001.
16. Khan 2004 Khan F. Rehabilitation in chronic neurological disorders. Australian Doctor 2004;5 November:27-34.
17. Khan 2007 Khan F, Turner-Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858. CD0006036.pub2]
18. Klein 1996 Klein LM, Forshew DA. The economic impact of ALS. Neurology 1996;47(4 suppl 2):S126-9.
19. Logroscino 2008 Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al.Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. Journal of Neurology, Neurosurgery and Psychiatry 2008;79(1):6-11.
20. McGuire 1996 McGuire D, Garrison L, Miller RG. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. Neurology 1996;46(5):1442- 4.
21. Miller 2007 Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858. CD0001447.pub2]
22. MNDA 2007 Research Strategy 2006-2012. Motor Neurone Disease Association, Northampton, UK 2007.
23. NICE 2003 National Institute for Clinical Excellence. Management of MS in primary and secondary care. Clinical guidelines 8 2003 November.
24. Rocha 2005 Rocha JA, Reis C, Simoes F, Fonseca J, Mendes Ribeiro J. Diagnostic investigation and multidisciplinary management in motor neuron disease. Journal of Neurology 2005 Dec;252(12):1435-47.
25. Shaw 1997 Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. Journal of Neurology 1997;244(Suppl 2):3S-14S.
26. Steultjens 2004 Steultjens EMJ, Dekker J, Bouter LM, van Schaardenburg D, van Kuyk MAH, van den Ende CHM. Occupational therapy for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 1002/14651858. CD003114.pub2]
27. Turner 2007 Turner MR, Al-Chalabi A. Clinical phenotypes. In: Kiernan M editor(s). The Motor Neurone Disease Handbook. Prymont: Australasian Medical Publishing Company Limited, 2007.
28. Turner-Stokes 2005 Turner-Stokes L, Disler P, Nair A, Wade DT. Multidisciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database of Systematic Reviews 2005, Issue 3.
29. Wade 1992 Wade DT. Measurement in Neurological Rehabilitation. Measurement in Neurological Rehabilitation. Oxford University Press, 1992.
30. Worms 2001 Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. Journal of the Neurological Sciences 2001;191(1-2):3-9.